Heron Therapeutics
Clinical trials sponsored by Heron Therapeutics, explained in plain language.
-
New shot battles Chemo's worst side effect
Symptom relief CompletedThis study tested whether a new drug combination (APF530) works better than a standard one (ondansetron) at preventing nausea and vomiting in cancer patients receiving strong chemotherapy. It involved 942 adults who were about to start their first round of this type of treatment.…
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 03, 2026 21:26 UTC
-
New drug tested to stop chemo sickness
Symptom relief CompletedThis study tested whether a new drug called APF530 works as well as an existing drug (Aloxi/palonosetron) at preventing nausea and vomiting caused by chemotherapy. The trial involved 1,428 cancer patients receiving chemotherapy that commonly causes these side effects. Researchers…
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
New pain treatment aims to slash opioid use after common surgery
Symptom relief CompletedThis study tested whether a non-opioid pain treatment called HTX 011 could help reduce the need for opioid painkillers after hernia repair surgery. The trial involved 63 adults undergoing hernia surgery who received the experimental treatment as part of their pain management plan…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
New pain relief options tested for cosmetic surgery recovery
Symptom relief CompletedThis study tested two experimental pain medications (HTX-011 and HTX-002) to see if they could effectively reduce pain after tummy tuck surgery. The trial involved 277 adults who underwent this cosmetic procedure. Researchers compared how well these medications worked against eac…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
New nerve block tested to ease pain after cosmetic surgery
Symptom relief CompletedThis study tested an experimental pain medication called HTX-011, given as a nerve block before breast augmentation surgery. Researchers wanted to see if it reduced pain better than standard options and lowered the need for opioid painkillers after the operation. The study involv…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
New drug aims to block pain after knee surgery, reduce need for opioids
Symptom relief CompletedThis study tested an experimental pain medication called HTX-011. It was injected directly into the surgical site during knee replacement surgery to see if it could better control pain in the first few days after the operation. Researchers compared it to a standard pain treatment…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC
-
Breakthrough pain treatment could reduce need for opioids after surgery
Symptom relief CompletedThis study tested whether a new medicine called HTX-011 could better control pain and reduce the need for opioid painkillers after hernia surgery. Researchers compared HTX-011 against both a placebo (saltwater injection) and a standard pain medicine in 418 patients. The medicine …
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Mar 30, 2026 14:27 UTC
-
New gel tested to numb foot pain after surgery
Symptom relief CompletedThis study tested three experimental gels designed to relieve pain after bunion surgery. The gels were applied directly to the surgical site and contained different combinations of pain-relieving medications. Researchers compared them to see which worked best at reducing pain in …
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
New knee surgery pain plan aims to ditch opioids
Symptom relief CompletedThis study tested a planned, non-opioid approach to managing pain after total knee replacement surgery. All 116 participants received an experimental long-acting numbing medicine (HTX-011) as part of a scheduled multi-drug plan. The main goal was to see how well this approach con…
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
New drug aims to slash pain pills after foot surgery
Symptom relief CompletedThis study tested a new pain medicine called HTX-011, which is applied directly to the surgical site during bunion surgery. The goal was to see if it could reduce pain better than a placebo (saltwater injection) or a standard local anesthetic, and if it could help patients use fe…
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
New shot aims to cut pain pills after foot surgery
Symptom relief CompletedThis study tested an experimental pain medication called HTX-011. It was injected directly into the surgical site during bunion surgery to see if it could reduce pain and the need for opioid painkillers afterward. The trial involved 78 people and measured their pain levels and me…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC
-
New shot aims to block surgery pain for days
Symptom relief CompletedThis study tested several new long-acting pain relief injections given during hernia surgery. The goal was to see if these new formulations could safely reduce pain for patients in the first 24 hours after their operation. Researchers compared different drug combinations to find …
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test if new nausea drug is safe for your heart
Knowledge-focused CompletedThis study checked whether a new anti-nausea medication called APF530 affects heart rhythm in healthy people. Researchers tested 56 healthy volunteers to see if the drug causes any changes to the heart's electrical activity. The study compared APF530 against a placebo and other m…
Sponsor: Heron Therapeutics • Aim: Knowledge-focused
Last updated Apr 03, 2026 21:39 UTC